Cytotoxicity screening of 23 engineered nanomaterials using a test matrix of ten cell lines and three different assays

Particle and Fibre Toxicology

Volumn 8, Issue , 2011, Pages

  Kroll, Alexandra ^a,g   Dierker, Christian ^a   Rommel, Christina ^a   Hahn, Daniela ^a   Wohlleben, Wendel ^b   Schulze Isfort, Christian ^c   Göbbert, Christian ^d   Voetz, Matthias ^e   Hardinghaus, Ferdinand ^f   Schnekenburger, Jürgen ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b BASF SE   (Germany)

^c EVONIK DEGUSSA GMBH   (Germany)

^d CWT Clean Tec AG   (Germany)

^e BAYER AG   (Germany)

^f Solvay Infra Bad Hönningen GmbH   (Germany)

^g SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM DERIVATIVE; ALUMINUM OXIDE HYDROXIDE; ALUMINUM TITANIUM ZIRCONIUM; BARIUM SULFATE; CARBON; CARBON BLACK; CERIUM OXIDE; METAL DERIVATIVE; NANOMATERIAL; STRONTIUM CARBONATE; TITANIUM DERIVATIVE; TITANIUM DIOXIDE; TITANIUM ZIRCONIUM; UNCLASSIFIED DRUG; ZIRCONIUM OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; ASSAY; BIOENGINEERING; CELL LINE; CELL METABOLISM; CELL STRESS; CELL VIABILITY; CHEMICAL COMPOSITION; CONTROLLED STUDY; CYTOTOXICITY TEST; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; ANIMAL; CELL DEATH; CHEMISTRY; DRUG EFFECT; METABOLISM; METHODOLOGY; PARTICLE SIZE; SOOT; STANDARD; TOXICITY TESTING;

ANIMALS; CELL DEATH; CELL LINE; HUMANS; NANOSTRUCTURES; OXIDATIVE STRESS; PARTICLE SIZE; REACTIVE OXYGEN SPECIES; SOOT; TOXICITY TESTS;

EID: 79951858161     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-8-9     Document Type: Article

References (53)

1. Oberdorster G, Finkelstein JN, Johnston C, Gelein R, Cox C, Baggs R, Elder AC. Acute pulmonary effects of ultrafine particles in rats and mice. Res Rep Health Eff Inst 2000, 5-74. disc 75-86.
2. Oberdorster E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 2004, 112:1058-1062. 10.1289/ehp.7021, 1247377, 15238277.
3. Oberdorster G. Pulmonary effects of inhaled ultrafine particles. Int Arch Occup Environ Health 2001, 74:1-8. 10.1007/s004200000185, 11196075.
4. Singh S, Shi T, Duffin R, Albrecht C, van Berlo D, Hohr D, Fubini B, Martra G, Fenoglio I, Borm PJ, Schins RP. Endocytosis, oxidative stress and IL-8 expression in human lung epithelial cells upon treatment with fine and ultrafine TiO2: role of the specific surface area and of surface methylation of the particles. Toxicol Appl Pharmacol 2007, 222:141-151. 10.1016/j.taap.2007.05.001, 17599375.
5. Sayes CM, Wahi R, Kurian PA, Liu Y, West JL, Ausman KD, Warheit DB, Colvin VL. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol Sci 2006, 92:174-185. 10.1093/toxsci/kfj197, 16613837.
6. Wang N, Huang D, Zhang J, Cheng J, Yu T, Zhang H, Bi S. Electrochemical Studies on the Effects of Nanometer-Sized Tridecameric Aluminum Polycation on Lactate Dehydrogenase Activity at the Molecular Level. The Journal of Physical Chemistry C 2008, 112:18034-18038.
7. Grassian VH, O'Shaughnessy PT, Adamcakova-Dodd A, Pettibone JM, Thorne PS. Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm. Environ Health Perspect 2007, 115:397-402. 10.1289/ehp.9469, 1849915, 17431489.
8. Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi H, Yeh JI, Zink JI, Nel AE. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-2134. 10.1021/nn800511k, 19206459.
9. Worle-Knirsch JM, Pulskamp K, Krug HF. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett 2006, 6:1261-1268. 10.1021/nl060177c, 16771591.
10. Monteiro-Riviere NA, Inman AO, Zhang LW. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 2009, 234:222-235. 10.1016/j.taap.2008.09.030, 18983864.
11. Kroll A, Pillukat MH, Hahn D, Schnekenburger J. Current in vitro methods in nanoparticle risk assessment: Limitations and challenges. Eur J Pharm Biopharm 2009, 72:370-377. 10.1016/j.ejpb.2008.08.009, 18775492.
12. L'Azou B, Jorly J, On D, Sellier E, Moisan F, Fleury-Feith J, Cambar J, Brochard P, Ohayon-Courtes C. In vitro effects of nanoparticles on renal cells. Part Fibre Toxicol 2008, 5:22. 2621238, 19099552.
13. Johnston HJ, Hutchison GR, Christensen FM, Peters S, Hankin S, Stone V. Identification of the mechanisms that drive the toxicity of TiO(2) particulates: the contribution of physicochemical characteristics. Part Fibre Toxicol 2009, 6:33. 10.1186/1743-8977-6-33, 2804608, 20017923.
14. Sayes C, Reed K, Subramoney S, Abrams L, Warheit D. Can in vitro assays substitute for in vivo studies in assessing the pulmonary hazards of fine and nanoscale materials?. Journal of Nanoparticle Research 2009, 11:421-431.
15. Warheit DB, Sayes CM, Reed KL. Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures?. Environ Sci Technol 2009, 43:7939-7945. 10.1021/es901453p, 19921917.
16. Veranth JM, Cutler NS, Kaser EG, Reilly CA, Yost GS. Effects of cell type and culture media on Interleukin-6 secretion in response to environmental particles. Toxicol In Vitro 2008, 22:498-509. 10.1016/j.tiv.2007.10.011, 2464571, 18178371.
17. Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, Weissleder R. Perturbational profiling of nanomaterial biologic activity. Proceedings of the National Academy of Sciences 2008, 105:7387-7392.
18. NanoCare Project NanoCare: Health related Aspects of Nanomaterials. Final Scientific Report 2009, Frankfurt a.M.: Dechema e. V, 1, NanoCare Project.
19. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009, 8:543-557. 10.1038/nmat2442, 19525947.
20. Schulze C, Kroll A, Lehr CM, Schäfer UF, Becker K, Schnekenburger J, Schulze Isfort C, Landsiedel R, Wohleben W. Not ready to use - overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2008, 2:51-61.
21. Landsiedel R, Ma-Hock L, Kroll A, Hahn D, Schnekenburger J, Wiench K, Wohlleben W. Testing Metal-Oxide Nanomaterials for Human Safety. Advanced Materials 2010, 22:2601-27. 10.1002/adma.200902658, 20512811.
22. Oberdorster G. Lung particle overload: implications for occupational exposures to particles. Regul Toxicol Pharmacol 1995, 21:123-135. 10.1006/rtph.1995.1017, 7784625.
23. Hext PM, Tomenson JA, Thompson P. Titanium dioxide: inhalation toxicology and epidemiology. Ann Occup Hyg 2005, 49:461-472. 10.1093/annhyg/mei012, 15790613.
24. Bermudez E, Mangum JB, Wong BA, Asgharian B, Hext PM, Warheit DB, Everitt JI. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol Sci 2004, 77:347-357. 10.1093/toxsci/kfh019, 14600271.
25. Pauluhn J. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol Sci 2009, 109:152-167. 10.1093/toxsci/kfp046, 19251949.
26. Jarabek A, Dourson M, Overton J. Interim Methods for Development of Inhalation Reference Concentrations. 1989, Washington, D.C.: U.S. Environmental Protection Agency, Agency USEP.
27. Tschumperlin DJ, Margulies SS. Alveolar epithelial surface area-volume relationship in isolated rat lungs. J Appl Physiol 1999, 86:2026-2033.
28. Lanone S, Rogerieux F, Geys J, Dupont A, Maillot-Marechal E, Boczkowski J, Lacroix G, Hoet P. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Part Fibre Toxicol 2009, 6:14. 10.1186/1743-8977-6-14, 2685765, 19405955.
29. Dallas CE, Williams PL. Barium: Rationale for a New Oral Reference Dose. Journal of Toxicology and Environmental Health, Part B: Critical Reviews 2001, 4:395-429.
30. Hussain SM, Braydich-Stolle LK, Schrand AM, Murdock RC, Yu KO, Mattie DM, Schlager JJ, Terrones M. Toxicity Evaluation for Safe Use of Nanomaterials: Recent Achievements and Technical Challenges. Advanced Materials 2009, 21:1549-1559.
31. Aam BB, Fonnum F. Carbon black particles increase reactive oxygen species formation in rat alveolar macrophages in vitro. Arch Toxicol 2007, 81:441-446. 10.1007/s00204-006-0164-3, 17119925.
32. Carter JM, Corson N, Driscoll KE, Elder A, Finkelstein JN, Harkema JN, Gelein R, Wade-Mercer P, Nguyen K, Oberdorster G. A comparative dose-related response of several key pro- and antiinflammatory mediators in the lungs of rats, mice, and hamsters after subchronic inhalation of carbon black. J Occup Environ Med 2006, 48:1265-1278. 10.1097/01.jom.0000230489.06025.14, 17159643.
33. Auffan M, Rose J, Bottero J-Y, Lowry GV, Jolivet J-P, Wiesner MR. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nano 2009, 4:634-641.
34. Pan Z, Lee W, Slutsky L, Clark RA, Pernodet N, Rafailovich MH. Adverse effects of titanium dioxide nanoparticles on human dermal fibroblasts and how to protect cells. Small 2009, 5:511-520. 10.1002/smll.200800798, 19197964.
35. Bar-Ilan O, Albrecht RM, Fako VE, Furgeson DY. Toxicity Assessments of Multisized Gold and Silver Nanoparticles in Zebrafish Embryos. Small 2009, 5:1897-1910. 10.1002/smll.200801716, 19437466.
36. Limbach LK, Grass RN, Stark WJ. Physico-Chemical Differences Between Particle- and Molecule-Derived Toxicity: Can We Make Inherently Safe Nanoparticles?. CHIMIA International Journal for Chemistry 2009, 63:38-43.
37. Patil S, Sandberg A, Heckert E, Self W, Seal S. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 2007, 28:4600-4607. 10.1016/j.biomaterials.2007.07.029, 2259388, 17675227.
38. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proceedings of the National Academy of Sciences 2008, 105:14265-14270.
39. Berg JM, Romoser A, Banerjee N, Zebda R, Sayes CM. The relationship between pH and zeta potential of ~30 nm metal oxide nanoparticle suspensions relevant to in vitro toxicological evaluations. Nanotoxicology 2009, 3:276-283.
40. Richardson JC, Scalera V, Simmons NL. Identification of two strains of MDCK cells which resemble separate nephron tubule segments. Biochim Biophys Acta 1981, 673:26-36.
41. Stearns RC, Paulauskis JD, Godleski JJ. Endocytosis of Ultrafine Particles by A549 Cells. Am J Respir Cell Mol Biol 2001, 24:108-115.
42. Li X, Hu Y, Jin Z, Jiang H, Wen J. Silica-Induced TNF-α and TGF-β1 Expression in RAW264.7 Cells are Dependent on Src-ERK/AP-1 Pathways. Toxicology Mechanisms and Methods 2009, 19:51-58. 10.1080/15376510802354201, 19778233.
43. Saxena RK, Vallyathan V, Lewis DM. Evidence for lipopolysaccharide-induced differentiation of RAW264.7 murine macrophage cell line into dendritic like cells. J Biosci 2003, 28:129-134. 10.1007/BF02970143, 12682436.
44. Huttunen K, Hyvarinen A, Nevalainen A, Komulainen H, Hirvonen MR. Production of proinflammatory mediators by indoor air bacteria and fungal spores in mouse and human cell lines. Environ Health Perspect 2003, 111:85-92. 10.1289/ehp.5478, 1241310, 12515684.
45. Sharma CS, Sarkar S, Periyakaruppan A, Barr J, Wise K, Thomas R, Wilson BL, Ramesh GT. Single-walled carbon nanotubes induces oxidative stress in rat lung epithelial cells. J Nanosci Nanotechnol 2007, 7:2466-2472. 10.1166/jnn.2007.431, 2740378, 17663266.
46. Takahashi K, Koga K, Linge H, Zhang Y, Lin X, Metz C, Al-Abed Y, Ojamaa K, Miller E. Macrophage CD74 contributes to MIF-induced pulmonary inflammation. Respiratory Research 2009, 10:33. 10.1186/1465-9921-10-33, 2681459, 19413900.
47. Shen BQ, Finkbeiner WE, Wine JJ, Mrsny RJ, Widdicombe JH. Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl- secretion. Am J Physiol Lung Cell Mol Physiol 1994, 266:L493-501.
48. Rousset M. The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie 1986, 68:1035-1040. 10.1016/S0300-9084(86)80177-8, 3096381.
49. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988, 106:761-771. 10.1083/jcb.106.3.761, 2115116, 2450098.
50. Jainchill JL, Aaronson SA, Todaro GJ. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J Virol 1969, 4:549-553. 375908, 4311790.
51. Chang JS, Chang KL, Hwang DF, Kong ZL. In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ Sci Technol 2007, 41:2064-2068. 10.1021/es062347t, 17410806.
52. Jakubowski W, Bartosz G. 2,7-dichlorofluorescin oxidation and reactive oxygen species: what does it measure?. Cell Biol Int 2000, 24:757-760. 10.1006/cbir.2000.0556, 11023655.
53. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983, 64:313-320. 10.1016/0022-1759(83)90438-6, 6199426.